COXIFARM® S is indicated for the prevention of coccidiosis in broilers and replacement pullets caused by Eimeria acervulina, Eimeria tenella and Eimeria maxima.
COXIFARM® S promotes a lower incidence of intestinal lesions and reduced mortality.
Among the main features of COXIFARM® S, the following stand out:
• Proven efficacy;
• Product microgranulated;
• Excellent fluidity and miscibility;
• Thermostability;
FORMULA
Each 100 g of COXIFARM® S contains:
Salinomycin ………………………………………….. 12.0 g
Excipient q.s………………………………………….100.0 g
DIRECTIONS FOR USE
The product must be mixed into broiler feed at a rate of 366.65 g to 600 g of COXIFARM® S per ton of feed, corresponding to 44 to 72 ppm of salinomycin, respectively.
Presentation
25 kg Bag.
Withdrawal Period
Poultry – slaughter: The slaughter of treated birds does not require a withdrawal period after the last administration.
Eggs: This product must not be administered to laying birds producing eggs for human consumption.
